We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Combination Product Cross-Labeling Topic of FDA Meeting
Combination Product Cross-Labeling Topic of FDA Meeting
March 25, 2005
The FDA is seeking advice on whether it should review and approve a new product that is labeled for use in conjunction with an existing product of a different type — an inquiry that indicates how the evolution of combination products is changing the regulatory landscape.